Comparing oxygen demand in critical covid-19 patients using single versus double doses of tocilizumabBrief Communication Published on 2023-05-012024-09-05 Journal: Saudi medical journal [Category] update2024, [키워드] Antiviral COVID-19 double dose oxygen demand Saudi Arabia Tocilizumab [DOI] 10.15537/smj.2023.44.5.20220755 PMC 바로가기 [Article Type] Brief Communication
Characterization of adverse events to hydroxychloroquine, ivermectin, azithromycin and tocilizumab in patients hospitalized due to COVID-19 in a Peruvian Social Health Insurance hospitalArtículo Original Published on 2023-03-282024-09-05 Journal: Revista peruana de medicina experimental y salud pública [Category] update2024, [키워드] Azithromycin Azitromicina COVID-19 Farmacovigilancia Hidroxicloroquina Hydroxychloroquine Ivermectin Ivermectina pharmacovigilance Tocilizumab [DOI] 10.17843/rpmesp.2023.401.11563 PMC 바로가기 [Article Type] Artículo Original
A 64-Year-Old Man Hospitalized for COVID-19 Pneumonia and Treated with Tocilizumab Who Developed Chronic Cavitary Pulmonary AspergillosisArticle Published on 2023-03-162024-09-05 Journal: The American journal of case reports [Category] update2024, [키워드] COVID-19 Dexamethasone itraconazole pulmonary aspergillosis Tocilizumab [DOI] 10.12659/AJCR.938359 PMC 바로가기 [Article Type] Article
Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial중증 COVID-19로 입원한 환자에서 토실리주맙과 바리시티닙의 비교: 공개 라벨, 무작위 대조 시험Article Published on 2023-03-012023-07-10 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), [키워드] Baricitinib COVID-19 Mortality paO2/fiO2 Tocilizumab [DOI] 10.1016/j.cmi.2022.10.015 PMC 바로가기
Tocilizumab Versus Baricitinib for the Treatment of COVID-19 in Patients With ObesityOriginal Research Article Published on 2023-02-192024-09-05 Journal: Journal of pharmacy practice [Category] update2024, [키워드] Baricitinib COVID-19 Critical care obesity Tocilizumab [DOI] 10.1177/08971900231158931 PMC 바로가기 [Article Type] Original Research Article
Statistical models to predict clinical outcomes with anakinra vs. tocilizumab treatments for severe pneumonia in COVID19 patientsLetter to the Editor Published on 2023-02-062024-09-05 Journal: European journal of internal medicine [Category] update2024, [키워드] acute respiratory distress syndrome Anakinra COVID-19 Mortality Tocilizumab [DOI] 10.1016/j.ejim.2023.01.024 PMC 바로가기 [Article Type] Letter to the Editor
A comparison of the effectiveness of different doses of tocilizumab and sarilumab in the treatment of severe COVID-19: a natural experiment due to drug shortages ☆Article Published on 2023-02-022024-09-05 Journal: International Journal of Infectious Diseases [Category] update2024, [키워드] COVID-19 IL-6 inhibitor sarilumab SARS-CoV-2 Tocilizumab [DOI] 10.1016/j.ijid.2023.01.041 PMC 바로가기 [Article Type] Article
Efficacy and safety of Tocilizumab, plasmapheresis and their combination in severe COVID-19: A randomized clinical trialReview Published on 2023-02-012023-07-11 Journal: International immunopharmacology [Category] COVID19(2023년), [키워드] COVID-19 Efficacy Plasmapheresis Safety Tocilizumab [DOI] 10.1016/j.intimp.2022.109623 PMC 바로가기 [Article Type] Review
Down-regulation of KLF2 in lung fibroblasts is linked with COVID-19 immunofibrosis and restored by combined inhibition of NETs, JAK-1/2 and IL-6 signalingArticle Published on 2023-01-212024-09-05 Journal: Clinical immunology (Orlando, Fla.) [Category] update2024, [키워드] Baricitinib COVID-19 DNase I Immunofibrosis KLF2 Tocilizumab [DOI] 10.1016/j.clim.2023.109240 PMC 바로가기 [Article Type] Article
[Should we interfere with the interleukin-6 receptor during COVID-19: What do we know?]Review Published on 2023-01-012023-07-11 Journal: Revue des maladies respiratoires [Category] COVID19(2023년), [키워드] Corticoïdes Corticosteroid COVID 19 COVID-19 interleukin-6 Interleukine 6 Mortalité Mortality Tocilizumab [DOI] 10.1016/j.rmr.2022.11.085 PMC 바로가기 [Article Type] Review